Bank Of America Corp Adverum Biotechnologies, Inc. Transaction History

Bank Of America Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.75 - $1.26 $968,825 - $1.63 Million	-1,291,767 Reduced 23.1%	4,300,023 $3.23 Million
Q1 2023 May 12, 2023	SELL	$0.62 - $0.85 $65 - $90	-106 Reduced -0.0%	5,591,790 $4.03 Million
Q4 2022 Feb 10, 2023	BUY	$0.54 - $10.3 $3.01 Million - $57.5 Million	5,581,844 Added 55529.69%	5,591,896 $3.24 Million
Q3 2022 Nov 14, 2022	BUY	$0.96 - $9.68 $5,809 - $58,583	6,052 Added 151.3%	10,052 $10,000
Q2 2022 Aug 12, 2022	SELL	$0.81 - $1.34 $21,780 - $36,031	-26,889 Reduced 87.05%	4,000 $4,000
Q1 2022 May 16, 2022	SELL	$1.23 - $1.95 $394,550 - $625,507	-320,773 Reduced 91.22%	30,889 $40,000
Q4 2021 Feb 08, 2022	BUY	$1.74 - $2.4 $237,913 - $328,156	136,732 Added 63.62%	351,662 $619,000
Q3 2021 Nov 15, 2021	SELL	$2.08 - $3.6 $203,883 - $352,875	-98,021 Reduced 31.32%	214,930 $467,000
Q2 2021 Sep 13, 2021	BUY	$3.36 - $10.56 $1.05 Million - $3.3 Million	312,951 New	312,951 $1.1 Million

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $681M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.